PND29 Comparing the Cost-Effectiveness of Avonex and Betaferon in the Management of Multiple Sclerosis in Iran
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.495
https://www.valueinhealthjournal.com/article/S1098-3015(11)02057-2/fulltext
Title :
PND29 Comparing the Cost-Effectiveness of Avonex and Betaferon in the Management of Multiple Sclerosis in Iran
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02057-2&doi=10.1016/j.jval.2011.08.495
First page :
A322
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
465